Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmytro Starenki

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 20, 2013
Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivoDmytro Starenki, Jong-In Park
Endocrinology and Metabolism (Seoul, Korea)|October 21, 2015
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In VivoDmytro Starenki, Jong In Park
Journal of Pediatric Oncology|March 26, 2016
Pediatric Medullary Thyroid CarcinomaDmytro Starenki, Jong-In Park
Cancers|March 26, 2014
The Role of STAT3 in Thyroid CancerNadiya Sosonkina, Dmytro Starenki, Jong-In Park
Genes & Genomics|December 23, 2014
Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell linesNadiya Sosonkina, Seung-Keun Hong, Dmytro Starenki, et al.
Cancer Biology & Therapy|October 28, 2016
Suppression of B-Raf<sup>V600E</sup> melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinoneSeung-Keun Hong, Dmytro Starenki, Pui-Kei Wu, et al.
International Journal of Oncology|October 16, 2013
Autophagy sensitivity of neuroendocrine lung tumor cellsSeung-Keun Hong, Jin-Hwan Kim, Dmytro Starenki, et al.
Cancer Biology & Therapy|May 6, 2017
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cellsDmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, et al.
Plos Computational Biology|November 29, 2018
powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoireHillary Koch, Dmytro Starenki, Sara J Cooper, et al.
International Journal of Molecular Sciences|April 28, 2019
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma CellsDmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|March 20, 2013
Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivoDmytro Starenki, Jong-In Park
Endocrinology and Metabolism (Seoul, Korea)|October 21, 2015
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In VivoDmytro Starenki, Jong In Park
Journal of Pediatric Oncology|March 26, 2016
Pediatric Medullary Thyroid CarcinomaDmytro Starenki, Jong-In Park
Cancers|March 26, 2014
The Role of STAT3 in Thyroid CancerNadiya Sosonkina, Dmytro Starenki, Jong-In Park
Genes & Genomics|December 23, 2014
Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell linesNadiya Sosonkina, Seung-Keun Hong, Dmytro Starenki, et al.
Cancer Biology & Therapy|October 28, 2016
Suppression of B-Raf<sup>V600E</sup> melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinoneSeung-Keun Hong, Dmytro Starenki, Pui-Kei Wu, et al.
International Journal of Oncology|October 16, 2013
Autophagy sensitivity of neuroendocrine lung tumor cellsSeung-Keun Hong, Jin-Hwan Kim, Dmytro Starenki, et al.
Cancer Biology & Therapy|May 6, 2017
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cellsDmytro Starenki, Seung-Keun Hong, Pui-Kei Wu, et al.
Plos Computational Biology|November 29, 2018
powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoireHillary Koch, Dmytro Starenki, Sara J Cooper, et al.
International Journal of Molecular Sciences|April 28, 2019
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma CellsDmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, et al.
Pageof 3